Internal Medicine · Los Angeles, CA
NPI
1417951963
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
240 N Virgil Ave Ste 7
Los Angeles, CA, 90004
Phone (213) 389-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$247K
7,055 services
Medicare patients, 2024
471
Average age 75
Drug cost, 2024
$2.1M
11,174 prescriptions
Company payments, 2025
$2,243
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alejandro E Gil was code 99213 (office e&m - established), 1,483 times for 366 patients. In total Alejandro E Gil billed 7,055 services in 105 codes, and Medicare paid $247K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,483 | 366 | $71.83 | $107K |
| 81003 Clinical Chemistry | Office | 899 | 266 | $2.20 | $1,978 |
| 82947 Clinical Chemistry | Office | 604 | 170 | $3.85 | $2,325 |
| 36415 Venipuncture Blood Collection | Office | 460 | 261 | $8.65 | $3,979 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 392 | 131 | $26.80 | $11K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 300 | 51 | $0.08 | $24.98 |
| 82962 Clinical Chemistry | Office | 252 | 58 | $3.21 | $809 |
| 93000 Electrocardiogram | Office | 212 | 173 | $10.57 | $2,242 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 198 | 46 | $0.34 | $67.19 |
| 96372 Injection Administration | Office | 195 | 117 | $11.77 | $2,294 |
| 99214 Office E&M - Established | Office | 186 | 87 | $93.30 | $17K |
| 81002 Clinical Chemistry | Office | 169 | 75 | $3.41 | $576 |
| 99203 Office E&M - New | Office | 127 | 127 | $81.34 | $10K |
| 99443 Telephone Services | Office | 126 | 70 | $87.49 | $11K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 115 | 78 | $39.09 | $4,495 |
By year: 2022 $149K for 3,163 services; 2023 $237K for 5,880 services; 2024 $247K for 7,055 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 899 | 266 | $2.20 | $1,978 |
| 82947 Clinical Chemistry | 604 | 170 | $3.85 | $2,325 |
| 36415 Venipuncture Blood Collection | 460 | 261 | $8.65 | $3,979 |
| 82962 Clinical Chemistry | 252 | 58 | $3.21 | $809 |
| 81002 Clinical Chemistry | 169 | 75 | $3.41 | $576 |
| 0241U Infectious Agent Detection by DNA/RNA | 48 | 40 | $139.78 | $6,709 |
Medicare prescription drug claims, 2024
In 2024, the drug Alejandro E Gil prescribed most often to Medicare patients was Gabapentin, with 602 prescriptions and refills. In total Alejandro E Gil wrote 11,174 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 602 | 781 | 155 | $4,094 |
| Pioglitazone Hcl Generic | 320 | 530 | 76 | $1,980 |
| Tamsulosin Hcl Generic | 271 | 423 | 53 | $3,056 |
| Levothyroxine Sodium Generic | 266 | 477 | 65 | $2,306 |
| Rosuvastatin Calcium Generic | 230 | 403 | 65 | $2,535 |
| Finasteride Generic | 228 | 373 | 58 | $2,379 |
| Atorvastatin Calcium Generic | 213 | 409 | 53 | $2,059 |
| Metformin Hcl Generic | 199 | 367 | 58 | $1,107 |
| Diclofenac Sodium Generic | 176 | 206 | 53 | $18K |
| Metoprolol Succinate Generic | 170 | 324 | 47 | $2,217 |
| Losartan Potassium Generic | 168 | 311 | 41 | $1,169 |
| Entresto Sacubitril/Valsartan | 167 | 202 | 26 | $112K |
| Furosemide Generic | 164 | 201 | 31 | $501 |
| Jardiance Empagliflozin | 164 | 234 | 41 | $126K |
| Amlodipine Besylate Generic | 163 | 235 | 34 | $351 |
Brand drugs: 2,300 claims; generic drugs: 8,653 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alejandro E Gil $2,243 ($2,243 in general payments such as food, travel and fees) from 14 companies. The largest payer was Amgen Inc. with $482.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 7 | $482 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $480 |
| Abbvie Inc. ABBV | 6 | $347 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $249 |
| Lilly USA, LLC LLY | 3 | $167 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $148 |
| Ardelyx, Inc. ARDX | 4 | $122 |
| Novo Nordisk Inc NVO | 2 | $56.21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50.31 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $33.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.